The shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) started off the last trading session with the price of $330.28 while closing the day with the price of $336.71. The shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) Rise 0.65% with the Gain of 6.43 points.
The shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) traded with the day volume of 1.54 Million shares whereas its average trading volume is 1.26 Million.
While analyzing the past performance of the stock we can see that the shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) Gain 5.58% in the last week while rising 4.91% in the last month. Past quarter performance shows the green light with 7.52%. The semi-annual and annual performance shows 7.79% and -19.12% respectively.
Some critical values of the shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) to be discussed here are: the beta which shows the value at 0.58 while Average True Range of Chipotle Mexican Grill, Inc. (NYSE:CMG) demonstrate the value at 10.87. The weekly and monthly volatility of the shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) are indicated at 3.49% and 2.88%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 62.37.
While studying the financial position of the shares of Chipotle Mexican Grill, Inc. (NYSE:CMG), we can see that the Market capitalization of the company is at 9.37 Billion. The shares outstanding for the company is 27.82 Million and the shares float stands at 27.49 Million. The income of the company stand at 176.2 Million while the sales stand at 4.48 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 6.16, Price to Earnings or P/E is at 54.66, Price to Sales P/S show the value of 2.09, the Return on Asset ROA stood at 0.086 and the Return on Equity ROE depicted at 0.126 while Return on Investment ROI is at 0.126.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) started its previous trading session at $8.32 and closed at $8.36 showing a Rise of 0 Percent.
The Company traded with an average Volume of 1.47 Million whereas, its Day Volume stood at 1.48 Million.
Looking at the performance of the stock, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Gain 0.72% in the last week in its shares price and 43.15% in the last month. Quarterly performance shows a green of 46.67 Percent while Semi-Annual and Annual performances shows a 20.29 and -25.69 percent respectively.
Beta for Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) stands at 2.58 while the ATR (average true range) is at 0.36. The Stock’s Weekly and Monthly Volatility is 3.67% and 5.42% respectively showing a RSI value of 70.8.
While studying the financial position of the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), we can see that the Market capitalization of the company is at 588.85 Million. The shares outstanding for the company is 70.44 Million and the shares float stands at 69.85 Million.
The Company generated an income of -54700000 and the sales of 11.7 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.78 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 50.33 respectively.
The Return on Assets stands at -0.313, ROE shows a value of -0.71 and ROI for Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) is -0.446 as of Trailing Twelve Months period.
